findmyKOL

Raymond Plodkowski, MD

Enriched profile

Physician, Endocrinology, Diabetes and Metabolism; weight management specialist · Scripps Clinic Del Mar

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 San Diego, CA · West · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusObesity+2
Active KOLfindmyKOL type: EliteLatest publication2018Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Raymond Plodkowski is Physician, Endocrinology, Diabetes and Metabolism; weight management specialist at Scripps Clinic Del Mar. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Raymond Plodkowski is Physician, Endocrinology, Diabetes and Metabolism at Scripps Clinic Del Mar, San Diego, CA. The public record shows 32 publications with 4,206 citations (h-index 13), centered on Obesity, Insulin Resistance, Metabolic Syndrome. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 20 companies.

  • Top research focus: Obesity
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Obesity2 trialsInsulin Resistance1 trialMetabolic Syndrome1 trial

Research focus

OpenAlex concept fingerprint
ObesityInsulin ResistanceMetabolic Syndrome

Drugs & molecules

across trials, industry payments and publications
Wegovygeneric · SemaglutideClinical trials—Industry payments238Publications—Zepboundgeneric · TirzepatideClinical trials—Industry payments152Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments146Publications—Saxendageneric · LiraglutideClinical trials—Industry payments70Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments53Publications—Contravegeneric · Bupropion / naltrexoneClinical trials—Industry payments20Publications—Synjardygeneric · Empagliflozin / metforminClinical trials—Industry payments14Publications—Tradjentageneric · LinagliptinClinical trials—Industry payments10Publications—Trulicitygeneric · DulaglutideClinical trials—Industry payments10Publications—Kerendiageneric · FinerenoneClinical trials—Industry payments3Publications—Qsymiageneric · Phentermine / topiramateClinical trials—Industry payments3Publications—Rezdiffrageneric · ResmetiromClinical trials—Industry payments3Publications—

Works with

trial sponsors and companies reporting payments
Novo Nordisk IncClinical trials—Industry payments325Lilly USA, LLCClinical trials—Industry payments215Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments92AstraZeneca Pharmaceuticals LPClinical trials—Industry payments54Currax Pharmaceuticals LLCClinical trials—Industry payments20Abbott LaboratoriesClinical trials—Industry payments7Abbvie Inc.Clinical trials—Industry payments3Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments3Madrigal PharmaceuticalsClinical trials—Industry payments3Vivus LLCClinical trials—Industry payments3Amarin Pharma Inc.Clinical trials—Industry payments1Ascendis Pharma Endocrinology IncClinical trials—Industry payments1Ascendis Pharma IncClinical trials—Industry payments1Dexcom, Inc.Clinical trials—Industry payments1Ethicon US, LLCClinical trials—Industry payments1KVK-Tech, Inc.Clinical trials—Industry payments1Medtronic, Inc.Clinical trials—Industry payments1Orexigen Therapeutics, IncClinical trials1Industry payments—Radius Health, Inc.Clinical trials—Industry payments1Sanofi-Aventis U.S. LLCClinical trials—Industry payments1Sequel Med Tech, LLCClinical trials—Industry payments1University of Nevada, Las VegasClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    78.2%
    Biguanide (metformin)43.4%
    Metformin Hcl Er70%Metformin Hcl30%
    Part D≥182 patients
    GLP-1 receptor agonist27.1%
    Ozempic73%Mounjaro18%Wegovy6%Trulicity3%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    9.4%
    l-Thyroxine7.9%
    Levothyroxine Sodium86%Synthroid14%
    Part D<11 patients
    l-Triiodothyronine1.5%
    Liothyronine Sodium100%
    Part D<11 patients
  • Nervous system

    8.3%
    Aminoketone4.4%
    Bupropion Xl67%Bupropion Hcl Sr33%
    Part D<11 patients
    Opioid Antagonist2.5%
    Naltrexone Hcl100%
    Part D≥13 patients

    + 1 more class in this area

All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/raymond-plodkowski-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Diplomate

    American Board of Obesity Medicine

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗
  • Endocrinology

    Diabetes and Metabolism fellowship, UC San Diego

    2002
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗
  • MD

    Medical College of Pennsylvania

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗
  • Diplomate

    National Board of Physician Nutrition Specialists

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗

Editorial & leadership roles

journal and society appointments
  • Diplomate

    American Board of Obesity Medicine

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.